Difference between revisions of "Normative:Hospitalization"
(Created page with "==Normative== === Variants and synonyms === * * ===Definition=== <small>Source:</small> === Encyclopaedic information === <small>Source:</small> ===Examples=== <bloc...") |
(new addition) |
||
| Line 1: | Line 1: | ||
==Normative== | ==Normative== | ||
=== Encyclopaedic information === | === Encyclopaedic information === | ||
Older patients and those with chronic medical conditions have a higher risk for hospitalization and death; however, SARS-CoV-2 infection may cause severe disease and death in patients of any age, even in the absence of any risk factors. | |||
<small>Source:</small> | <small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | ||
===Examples=== | ===Examples=== | ||
<blockquote></blockquote><small>Source:</small> | <blockquote>A large randomized trial evaluating colchicine in outpatients with COVID-19 (COLCORONA) did not reach its primary efficacy endpoint of reducing '''hospitalizations''' and death.</blockquote><small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small><blockquote>Endpoint events occurred in three of 291 participants (1%) in the sotrovimab arm and 21 of 292 participants (7%) in the placebo arm (P = 0.002), resulting in a 6% absolute reduction and an 85% relative reduction in '''hospitalizations''' or death among the sotrovimab recipients compared to the placebo recipients.</blockquote><small>Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf</small> | ||
===Collocations=== | ===Collocations=== | ||
* hospitalization and death | |||
* COVID-19 related hospitalizations | |||
* reduction in hospitalizations | |||
* | * | ||
| Line 26: | Line 21: | ||
===Keyness=== | ===Keyness=== | ||
* | * hospitalize: 7 | ||
Latest revision as of 18:44, 3 March 2022
Normative
Encyclopaedic information
Older patients and those with chronic medical conditions have a higher risk for hospitalization and death; however, SARS-CoV-2 infection may cause severe disease and death in patients of any age, even in the absence of any risk factors.
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Examples
A large randomized trial evaluating colchicine in outpatients with COVID-19 (COLCORONA) did not reach its primary efficacy endpoint of reducing hospitalizations and death.
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Endpoint events occurred in three of 291 participants (1%) in the sotrovimab arm and 21 of 292 participants (7%) in the placebo arm (P = 0.002), resulting in a 6% absolute reduction and an 85% relative reduction in hospitalizations or death among the sotrovimab recipients compared to the placebo recipients.
Source: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf
Collocations
- hospitalization and death
- COVID-19 related hospitalizations
- reduction in hospitalizations
Keyness
- hospitalize: 7